Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.
Not yet recruiting · NCT07757412 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma. | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 2 | 2026-08-11 | NCT07757412 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Odense University Hospital | 253 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AUH | Aarhus | Denmark | 1 |
| Helsinki University Hospital Comprehensive Cancer Center | Helsinki | Finland | 2 |
| North Estonia Medical Centre | Tallinn | Estonia | 4 |
| Oslo University Hospital, Oslo Myeloma Centre | Oslo | Norway | 1 |
| OUH | Odense | Denmark | 1 |
| St. Olavs hospital | Trondheim | Norway | 17 |
| Stavanger University Hospital | Stavanger | Norway | 36 |
| Tartu University Hospital | Tartu | Estonia | 13 |
| Vestfold Hospital | Tønsberg | Norway | 3 |